Newsroom
Latest News
WASHINGTON – U.S. Rep. Diana DeGette (D-CO) today offered the following statement after House passage of a stand-alone measure to repeal the military's "Don't Ask Don't Tell" policy.
Congresswoman Diana DeGette (CO-01) today hailed the approval of the second human treatment trial using human embryonic stem cells. The test, just approved by the FDA, will be conducted by Advanced Cell Technology (ACT) and will focus on Stargardt's disease. Medical professionals believe a successful human trial will open the doors to the treatment of other, more common eye diseases such as macular degeneration.
WASHINGTON—Congresswoman Diana DeGette (CO-1) applauded the enactment of the Small Business Lending Fund Act, signed into law today by President Barack Obama. The bill, which passed the U.S. House of Representatives last week by a vote of 237-187, provides tax cuts and credits for small businesses, as well as provides community banks with funding to increase lending opportunities to small businesses.
(WASHINGTON, DC) - Congresswoman Diana DeGette (D-CO) today applauded Senate passage of the small business lending bill. On June 17th, DeGette joined the U.S. House when they passed similar legislation.
Act now on embryonic stem-cell research funds
September 15, 2010
By: The Denver Post Editorial Board
Congress last week was given the needed breathing room to pass a legislative solution that allows for federal financing of embryonic stem-cell research.